Jinhai Medical Technology Limited operates as a Hong Kong-listed company based in Shanghai, China, specializing in minimally invasive surgery solutions, medical products, and related services in the Chinese Mainland.
Jinhai Medical Technology Limited partners with Digital Health China Technologies Co. Ltd. to explore joint business operations and equity investment in medical AI. The collaboration focuses on integrating medical big data and AI-driven healthcare solutions. Both companies aim to leverage their expertise in healthcare services and digital health technology.
Nov 2026Insight, China's Pharmaceutical IndustryNews article
Jinhai Med Tech (stock code **02225**) is now included in the Stock Connect program, linking the Shanghai and Shenzhen stock exchanges. The move allows international investors broader access to the company’s shares. The inclusion takes effect on **October 13, 2026**.
Jinhai Med Tech (stock code 02225) updates its board of directors with new appointments or removals. The company operates in the medical technology sector, though specific details about the changes remain unspecified in the announcement.
Jinhai Med Tech (stock code 02225) reports a net profit loss of **HK$4.4 million** in its latest interim financial results. The company, listed on the Hong Kong Stock Exchange, discloses this figure as part of its earnings attributable to owners. No additional operational details or performance drivers are provided in the announcement.
